Human Growth Hormone Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

How Big Is the Human Growth Hormone Market Expected to Be, and What Will Its Growth Rate Be?
There has been a swift expansion in the human growth hormone market size in the past few years. An increase from $4.75 billion in 2024 to $5.23 billion in 2025 is expected, exhibiting a compound annual growth rate (CAGR) of 10.1%. The surge during the previous years can be credited to the escalating incidence of growth impairments, heightened consciousness regarding hormone treatments, widening usage in sports medicine, an expanding elderly population, and enhanced healthcare infrastructure.

Expectations show a solid expansionation in the human growth hormone market size in the upcoming years. It is predicted to surge to $7.6 billion by 2029, with a compound annual growth rate (CAGR) of 9.8%. The projected growth can be credited to the advent of personalized medicine, increased global healthcare expenditure, the upsurge in the use of recombinant DNA technology, heightened demand for hormone replacement therapies, and an increasing number of endocrine disorders. Key trends during the forecast period will include extending distribution networks in emerging markets, incorporating artificial intelligence in the creation of medications, a focus on environmentally friendly manufacturing processes, the development of long-lasting formulations, and the use of combination therapies for improved results.

What Is Contributing to the Growth of the Human Growth Hormone Market?
The human growth hormone market is anticipated to expand due to the increasing cognizance of treatment procedures. These procedures, which involve medical techniques to treat or manage health conditions, have become more recognized due to enhanced medical technology, greater information accessibility via digital platforms, and a heightened societal concern for health. Particularly, human growth hormone (HGH) treatments have received considerable media coverage and public awareness, underscoring the advantages of contemporary medical interventions and promoting a broader understanding of treatment procedures. As per the report titled The 2022 National Survey on Drug Use and Health (NSDUH) by the Substance Abuse and Mental Health Services Administration (SAMHSA) in November 2023, the number of adolescents aged 12 to 17 receiving treatment for major depressive episodes (MDE) increased from 40.6% out of 5.0 million in 2021 to 56.8% out of 4.8 million in 2022. As a result, the increased cognizance of treatment techniques continues to fuel the human growth hormone market's growth. The augmenting healthcare expenditure is also propelling the human growth hormone market's growth. This expenditure comprises all sums spent on health products, services, and interventions dedicated to health improvement and sustenance. Human growth hormone (HGH) therapy provides a novel way to decrease health expenditure by tackling the root causes of long-term costs, enhancing patient recovery and quality of life, and potentially warding off expensive chronic ailments. To illustrate, a report published by the Office for National Statistics in May 2023 stated that the UK's healthcare spending grew by 5.6% between 2022 and 2023, in contrast to a growth of 0.9% in 2022, amounting to approximately $317.63 billion (£292 billion) in 2023. Thus, the escalating healthcare expenditure is propelling the human growth hormone market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15825&type=smp

Who Are the Dominant Companies Influencing Human Growth Hormone Market Trends?
Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., Shanghai United Imaging Healthcare Co. Ltd., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

How Is the Human Growth Hormone Market Evolving?
Prominent businesses in the human growth hormone market are intensifying their attention on drug advancement and approval to enhance their medical offerings and bring forth improved treatment solutions. The creation of drugs is a thorough and arduous process that necessitates several stages to validate the safety, potency, and quality of a new drug prior to its market release. For instance, in June 2023, Pfizer Inc., an American biopharmaceutical firm, alongside OPKO Health Inc., another biopharmaceutical and diagnostics company also based in the US, declared that the Food and Drug Administration (FDA) had approved NGENLA (somatrogon-ghla). This treatment provides a simpler dosing plan and heightens patient compliance in comparison to daily shots. It enables children suffering from growth hormone deficiency the flexibility to decrease their injection frequency from daily to weekly. This FDA approval was reinforced by a Phase 3 study that proved the non-inferiority of NGENLA when compared with daily somatropin, possessing a similar somatropin safety profile.

What Are the Different Segmentations in the Human Growth Hormone Market?
The human growth hormone market covered in this report is segmented -

1) By Product: Liquid, Powder
2) By Brand: Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Others Brands
3) By Route Of Administration: Oral, Intravenous, Intramuscular, Subcutaneous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Specialty Pharmacy
5) By Application: Growth Hormone (GH) Deficiency, Adult Growth Hormone (GH) Deficiency, Pediatric Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Other Applications

Subsegments:
1) By Liquid: Pre-Filled Liquid Syringes, Vials Of Liquid Growth Hormone
2) By Powder: Reconstitutable Powder, Freeze-Dried Powder

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

Which Region Is at the Forefront of the Human Growth Hormone Market?
North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Human Growth Hormone Global Market Report?

- Market Size Analysis: Analyze the Human Growth Hormone Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Human Growth Hormone Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Human Growth Hormone Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Human Growth Hormone Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15825

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.